FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Svatek

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Urothelium

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
William M Hilton; Yair Lotan; Dipen J Parekh; Joseph W Basler; Robert S Svatek
Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
Dipen J Parekh; Barbara Ercole; John Fitzgerald; Jamie Messer; Robert S Svatek
Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy.
Shahrokh F Shariat; Guru Sonpavde; Robert S Svatek; Scott T Tagawa; Quoc-Dien Trinh; evanguelos xylinas; Marko Babjuk; Eugene K Cha; fianceeyi chun; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Abdennabi Joual; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Michael Rink; Douglas S Scherr; Mithat Gonen
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Svatek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: William M Hilton; Yair Lotan; Dipen J Parekh; Joseph W Basler; Robert S Svatek
Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
BJU international 2013;111(7):1054-60.
2013: Dipen J Parekh; Barbara Ercole; John Fitzgerald; Jamie Messer; Robert S Svatek
Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy.
The Journal of urology 2013;189(2):474-9.
2013: Shahrokh F Shariat; Guru Sonpavde; Robert S Svatek; Scott T Tagawa; Quoc-Dien Trinh; evanguelos xylinas; Marko Babjuk; Eugene K Cha; fianceeyi chun; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Abdennabi Joual; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Michael Rink; Douglas S Scherr; Mithat Gonen
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
European urology 2013;63(2):371-8.
2013: Thomas F Chromecki; Siamak Daneshmand; Matthieu Durand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Karl Pummer; Michael Rink; Marko Babjuk; Patrick J Bastian; Antonin Brisuda; Maximilian Burger; Eugene K Cha; Robert S Svatek; Derya Tilki; Shahrokh F Shariat
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU international 2013;111(2):249-55.
2013: Ashish M Kamat; Peter E Clark; Michael Droller; Jason R Gee; Nicholas Hegarty; Paul K Hegarty; Lawrence C Jenkins; Yair Lotan; Bernd J Schmitz-Dräger; Shahrokh F Shariat; Robert S Svatek; Bas W G van Rhijn; evanguelos xylinas; Pierre I Karakiewicz
ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers.
European urology 2013;63(1):4-15.
2013: Michael Rink; Douglas S Scherr; Robert S Svatek; Scott T Tagawa; Derya Tilki; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Eugene K Cha; fianceeyi chun; Evi Comploj; Roland Dahlem; Siamak Daneshmand; Talia Faison; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
BJU international 2013;111(1):74-84.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Scott T Tagawa; Derya Tilki; Quoc-Dien Trinh; Bjoern G Volkmer; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Felix K Chun; Siamak Daneshmand; John P Fitzgerald; Yves Fradet; Hans-Martin Fritsche; David A Green; Jens Hansen; Ashish M Kamat; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Robert S Svatek
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World journal of urology 2012;30(6):807-14.
2012: Thomas F Chromecki; Colin P Dinney; Harun Fajkovic; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Julian Mauermann; Francesco Montorsi; Giacomo Novara; Karl Pummer; Eila Skinner; Christian G Stief; Robert S Svatek; Derya Tilki; Bjoern G Volkmer; Patrick J Bastian; Eugene K Cha; Shahrokh F Shariat
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World journal of urology 2012;30(6):753-9.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Robert S Svatek; Marko Babjuk; Eugene K Cha; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Margit Fisch; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Richard K Lee; Yair Lotan; Vitaly Margulis; Giacomo Novara; Armin Pycha; Jay D Raman
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
European urology 2012;62(4):677-84.
2012: Yair Lotan; Shahrokh F Shariat; Robert S Svatek; Catherine M Tangen; Ian M Thompson; Ramy F Youssef; Phyllis J Goodman; Eric A Klein
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT.
The Journal of urology 2012;187(6):2005-10.
2012: William M Hilton; Robert S Svatek
Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
European urology 2012;61(5):1062-3.
2012: Debasish Sundi; Robert S Svatek; Christopher G Wood; Colin P Dinney; Vitaly Margulis; Surena F Matin; Ashish M Kamat
Upper tract urothelial carcinoma: impact of time to surgery.
Urologic oncology 2012;30(3):266-72.
2012: Robert S Svatek; Pascal Zehnder
Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer.
Current urology reports 2012;13(2):115-21.
2012: Christopher E Barbieri; Eugene K Cha; Thomas F Chromecki; Allison Dunning; Pierre I Karakiewicz; Yair Lotan; Madhu Mazumdar; Douglas S Scherr; Maxine Sun; Robert S Svatek; Shahrokh F Shariat
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU international 2012;109(5):685-90.
2012: Shahrokh F Shariat; Pierre I Karakiewicz; Maximilian Burger; Yair Lotan; Patrick J Bastian; Firas Abdollah; Harun Fajkovic; Siamak Daneshmand; Arthur I Sagalowsky; Eugene K Cha; Behfar Ehdaie; Robert S Svatek; Thomas Clozel; Hans-Martin Fritsche; Giacomo Novara; Yves Fradet; Scott G David; Michael Rink; Thomas F Chromecki; Jonathan I Izawa; Wassim Kassouf; Douglas S Scherr; Felix K Chun; Derya Tilki; Guru Sonpavde; Mithat Gonen
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
European urology 2012;61(2):237-42.
2012: Woonyoung Choi; Colin Dinney; I-Ling Lee; Lauren Marquis; David J McConkey; Jay B Shah; Yu Shen; Robert S Svatek; Mai Tran; Sijin Wen; Dasom Yu; Liana Adam; Arlene Siefker-Radtke
p63 expression defines a lethal subset of muscle-invasive bladder cancers.
PloS one 2012;7(1):e30206.
2011: Guru Sonpavde; Robert S Svatek; Derya Tilki; Eila Skinner; Gilad E Amiel; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Myrna M Khan; Richard Lee; Seth P Lerner; Yair Lotan; Giacomo Novara; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
BJU international 2011;108(5):687-92.
2011: William M Hilton; Dipen J Parekh; Guru Sonpavde; Barbara Ercole; Rita Ghosh; Robert S Svatek
Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
Expert review of anticancer therapy 2011;11(6):949-57.
2011: Robert S Svatek; Dipen J Parekh
Editorial comment.
Urology 2011;77(4):876-7.
2011: Guru Sonpavde; Myrna M Khan; Robert S Svatek; Richard Lee; Giacomo Novara; Derya Tilki; Seth P Lerner; Gilad E Amiel; Eila Skinner; Pierre I Karakiewicz; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Douglas S Scherr; Vincenzo Ficarra; Colin P Dinney; Yair Lotan; Yves Fradet; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
The Journal of urology 2011;185(4):1216-21.
2011: Robert S Svatek; Shahrokh F Shariat; Giacomo Novara; Eila C Skinner; Yves Fradet; Patrick J Bastian; Ashish M Kamat; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Vincenzo Ficarra; Bjoern G Volkmer; Hendrik Isbarn; Colin P Dinney
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
BJU international 2011;107(6):898-904.
2011: Guru Sonpavde; Myrna M Khan; Seth P Lerner; Robert S Svatek; Giacomo Novara; Pierre I Karakiewicz; Eila Skinner; Derya Tilki; Wassim Kassouf; Yves Fradet; Colin P Dinney; Hans-Martin Fritsche; Jonathan I Izawa; Patrick J Bastian; Vincenzo Ficarra; Mark P Schoenberg; Arthur I Sagalowsky; Yair Lotan; Shahrokh F Shariat
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
The Journal of urology 2011;185(2):456-61.
2011: Robert S Svatek; Yair Lotan
Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigen.
Cancer prevention research (Philadelphia, Pa.) 2011;4(2):277-83.
2011: Philipp Nuhn; Eila Skinner; Guru Sonpavde; Robert S Svatek; Derya Tilki; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Hendrik Isbarn; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Francesco Montorsi; Stefan C Müller; Giacomo Novara; Shahrokh F Shariat
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Urologia internationalis 2011;87(1):42-8.
2010: Robert S Svatek; Mark B Fisher; Michael B Williams; Surena F Matin; Ashish M Kamat; H Barton Grossman; Graciela M Nogueras-González; Diana L Urbauer; Colin P Dinney
Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy.
Urology 2010;76(6):1419-24.
2010: Robert S Svatek; Jay B Shah; Jinliang Xing; David Chang; Jie Lin; David J McConkey; Xifeng Wu; Colin P Dinney
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer.
Cancer 2010;116(19):4513-9.
2010: Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene Siefker-Radtke; Randall E Millikan; Colin P N Dinney
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4461-7.
2010: Derya Tilki; Robert S Svatek; Giacomo Novara; Michael Seitz; Guilherme Godoy; Pierre I Karakiewicz; Wassim Kassouf; Yves Fradet; Hans-Martin Fritsche; Guru Sonpavde; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Oliver Reich; Shahrokh F Shariat
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
The Journal of urology 2010;184(3):888-94.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Giacomo Novara; Michael Seitz; Guru Sonpavde; Amit Gupta; Wassim Kassouf; Yves Fradet; Vincenzo Ficarra; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Christian G Stief; Oliver Reich; Shahrokh F Shariat
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
The Journal of urology 2010;184(2):470-4.
2010: Derya Tilki; Oliver Reich; Pierre I Karakiewicz; Giacomo Novara; Wassim Kassouf; Süleyman Ergün; Yves Fradet; Vincenzo Ficarra; Guru Sonpavde; Christian G Stief; Eila Skinner; Robert S Svatek; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
European urology 2010;58(1):112-7.
2010: Keren Elias; Robert S Svatek; Samir Gupta; Richard Ho; Yair Lotan
High-risk patients with hematuria are not evaluated according to guideline recommendations.
Cancer 2010;116(12):2954-9.
2010: Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Vincenzo Ficarra; Yves Fradet; Yair Lotan; Hendrik Isbarn; Umberto Capitanio; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Colin P Dinney; Seth P Lerner; Mark P Schoenberg; Bjoern G Volkmer; Arthur I Sagalowsky; Shahrokh F Shariat
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
The Journal of urology 2010;183(6):2165-70.
2010: Derya Tilki; Oliver Reich; Robert S Svatek; Pierre I Karakiewicz; Wassim Kassouf; Giacomo Novara; Vincenzo Ficarra; Daher C Chade; Hans-Martin Fritsche; Niklas Gerwens; Jonathan I Izawa; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
The Journal of urology 2010;183(5):1757-63.
2010: Shahrokh F Shariat; Robert S Svatek; Derya Tilki; Eila Skinner; Pierre I Karakiewicz; Umberto Capitanio; Patrick J Bastian; Bjoern G Volkmer; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish M Kamat; Colin P Dinney; Yair Lotan; Michael J Marberger; Yves Fradet
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
BJU international 2010;105(10):1402-12.
2010: Robert S Svatek; Mark B Fisher; Surena F Matin; Ashish M Kamat; H Barton Grossman; Graciela M Nogueras-González; Diana L Urbauer; Kathleen A Kennedy; Colin P Dinney
Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria.
The Journal of urology 2010;183(3):929-34.
2010: Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
European urology 2010;57(2):300-9.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
The Journal of urology 2010;183(1):87-93.
2009: Robert S Svatek; Arlene Siefker-Radtke; Colin P N Dinney
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(6 Suppl 4):S228-31.
2009: David J McConkey; Woonyoung Choi; Lauren Marquis; Frances Martin; Michael B Williams; Jay Shah; Robert S Svatek; Aditi Das; Liana Adam; Ashish Kamat; Arlene Siefker-Radtke; Colin P N Dinney
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
Cancer metastasis reviews 2009;28(3-4):335-44.
2009: Robert S Svatek; Mark Munsell; Jordan M Kincaid; Paul Hegarty; Joel W Slaton; J Erik Busby; Kris E Gaston; Philippe E Spiess; Lance C Pagliaro; Pheroze Tamboli; Curtis A Pettaway
Association between lymph node density and disease specific survival in patients with penile cancer.
The Journal of urology 2009;182(6):2721-7.
2009: Ashish M Kamat; Robert S Svatek
Editorial comment.
The Journal of urology 2009;182(6):2630; discussion 2631.
2009: Mark B Fisher; Robert S Svatek; Paul K Hegarty; John E McGinniss; Curtis Hightower; H Barton Grossman; Ashish M Kamat; Colin P Dinney; Surena F Matin
Cardiac history and risk of post-cystectomy cardiac complications.
Urology 2009;74(5):1085-9.
2009: Robert S Svatek; Colin P N Dinney
Words of wisdom. Re: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
European urology 2009;56(4):745-6.
2009: Robert S Svatek; Colin P N Dinney
Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7.
European urology 2009;56(1):217-8.
2009: Robert S Svatek; Elenir B C Avritscher; Linda S Elting; Colin P Dinney
High risk populations and cystectomy outcomes.
The Journal of urology 2009;182(1):10-1.
2009: Yair Lotan; Keren Elias; Robert S Svatek; Aditya Bagrodia; Geoffrey Nuss; Brett Moran; Arthur I Sagalowsky
Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
The Journal of urology 2009;182(1):52-7; discussion 58.
2009: Robert S Svatek; Ashish M Kamat; Colin P Dinney
Novel therapeutics for patients with non-muscle-invasive bladder cancer.
Expert review of anticancer therapy 2009;9(6):807-13.
2009: Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Nazareno Suardi; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Kevin Slawin; Shahrokh F Shariat
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
The Prostate 2009;69(8):886-94.
2009: Robert S Svatek; Philippe E Spiess; Debasish Sundi; Shi-Ming Tu; Nizar M Tannir; Gordon A Brown; Ashish M Kamat; Christopher G Wood; Louis L Pisters
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
Cancer 2009;115(6):1310-7.
2009: Shahrokh F Shariat; Robert S Svatek
Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):626-8.
2009: Robert S Svatek; Shahrokh F Shariat
Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
European urology 2009;55(1):185-6.
2008: Robert S Svatek; Y Lotan; P I Karakiewizc; S F Shariat
Screening for bladder cancer using urine-based tumor markers.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2008;60(4):247-53.
2008: M P Herman; Robert S Svatek; Y Lotan; P I Karakiewizc; S F Shariat
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2008;60(4):217-35.
2008: Robert S Svatek; Shahrokh F Shariat
Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
European urology 2008;54(3):690-1.
2008: Robert S Svatek; Yair Lotan
Is there a rationale for bladder cancer screening?
Current urology reports 2008;9(5):339-41.
2008: Steven M Lucas; Robert S Svatek; Guadencio Olgin; Yull Arriaga; Wareef Kabbani; Arthur I Sagalowsky; Yair Lotan
Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
BJU international 2008;102(2):172-6.
2008: Robert S Svatek; Jose A Karam; Claus G Roehrborn; Pierre I Karakiewicz; Kevin Slawin; Shahrokh F Shariat
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3362-6.
2008: Robert S Svatek; Michael J Shulman; Elie A Benaim; Thomas E Rogers; Vitaly Margulis
Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate cancer diagnosis.
The Journal of urology 2008;179(6):2192-5; discussion 2195-6.
2008: Jose A Karam; Robert S Svatek; Pierre I Karakiewicz; Andrea Gallina; Claus G Roehrborn; Kevin Slawin; Shahrokh F Shariat
Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1418-22.
2008: Robert S Svatek; J Jack Lee; Claus G Roehrborn; Scott M Lippman; Yair Lotan
Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
Cancer 2008;112(5):1058-65.
2008: Robert S Svatek; Jose A Karam; Pierre I Karakiewicz; Andrea Gallina; Roberto Casella; Claus G Roehrborn; Shahrokh F Shariat
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
The Journal of urology 2008;179(2):478-84; discussion 484.
2008: Yair Lotan; Robert S Svatek; Núria Malats
Screening for bladder cancer: a perspective.
World journal of urology 2008;26(1):13-8.
2008: Shahrokh F Shariat; Robert S Svatek; Wareef Kabbani; Jochen Walz; Yair Lotan; Pierre I Karakiewicz; Claus G Roehrborn
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
BJU international 2008;101(2):232-7.
2007: Yair Lotan; Robert S Svatek
Cost-effectiveness of bladder cancer screening.
Expert review of pharmacoeconomics & outcomes research 2007;7(6):627-32.
2007: Joshua M Stern; Robert S Svatek; Sangtae Park; Michael Hermann; Yair Lotan; Arthur I Sagalowsky; Jeffrey A Cadeddu
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
BJU international 2007;100(2):287-90.
2007: Robert S Svatek; Jose A Karam; Thomas E Rogers; Michael J Shulman; Vitaly Margulis; Elie A Benaim
Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens.
Prostate cancer and prostatic diseases 2007;10(3):279-82.
2006: Robert S Svatek; Yair Lotan; Michael P Herman; Michael Hermann; David A Duchene; Arthur I Sagalowsky; Jeffrey A Cadeddu
The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
The Journal of urology 2006;176(4 Pt 1):1321-5; discussion 125.
2006: Khaled F Abdel-Aziz; J Kyle Anderson; Robert S Svatek; Vitaly Margulis; Arthur I Sagalowsky; Jeffrey A Cadeddu
Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
Journal of endourology / Endourological Society 2006;20(9):627-31.
2006: Yair Lotan; Robert S Svatek; Arthur I Sagalowsky
Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.
Cancer 2006;107(5):982-90.
2006: Robert S Svatek; J Jack Lee; Claus G Roehrborn; Scott M Lippman; Yair Lotan
The cost of prostate cancer chemoprevention: a decision analysis model.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1485-9.
2006: Robert S Svatek; Arthur I Sagalowsky; Yair Lotan
Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.
Urologic oncology 2006;24(4):338-43.
2006: Robert S Svatek; Michael P Herman; Yair Lotan; Roberto Casella; Jer-Tsong Hsieh; Arthur I Sagalowsky; Shahrokh F Shariat
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
Cancer 2006;106(8):1701-7.
2006: Robert S Svatek; Pierre I Karakiewicz; Michael J Shulman; Jose A Karam; Paul Perrotte; Elie A Benaim
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
European urology 2006;49(4):666-74.
2006: Robert S Svatek; Robert Sims; J Kyle Anderson; Khaled F Abdel-Aziz; Jeffrey A Cadeddu
Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
Urology 2006;67(3):508-12.
2006: Robert S Svatek; Michael J Shulman; Pankaj K Choudhary; Elie A Benaim
Critical analysis of prostate-specific antigen doubling time calculation methodology.
Cancer 2006;106(5):1047-53.
2006: J Kyle Anderson; Edward D Matsumoto; Khaled F Abdel-Aziz; Robert S Svatek; Jeffrey A Cadeddu
Serum laboratory values following uncomplicated laparoscopic urological surgery.
The Journal of urology 2006;175(1):167-9.
2005: Vitaly Margulis; Edward D Matsumoto; Robert S Svatek; Wareef Kabbani; Jeffrey A Cadeddu; Yair Lotan
Application of novel hemostatic agent during laparoscopic partial nephrectomy.
The Journal of urology 2005;174(2):761-4.
2005: Robert S Svatek; David Lee; Yair Lotan
Correlation of office-based cystoscopy and cytology with histologic diagnosis: how good is the reference standard?
Urology 2005;66(1):65-8.
2005: Robert S Svatek; Vivyenne Roche; Jacqueline Thornberg; Philippe E Zimmern
Normative values for the American Urological Association Symptom Index (AUA-7) and short form Urogenital Distress Inventory (UDI-6) in patients 65 and older presenting for non-urological care.
Neurourology and urodynamics 2005;24(7):606-10.